Literature DB >> 1425711

In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci.

J P Guggenbichler1, D Berchtold, F Allerberger, H Bonatti, J Hager, W Pfaller, M P Dierich.   

Abstract

An in vitro model was used to study whether and how catheter infections can be cured. Silastic catheters were "infected" with Staphylococcus aureus ATCC 25923 and Staphylococcus epidermidis KH11 and V2; these "infections" were then treated with 24, 48 and 96 h continuous infusions of various antimicrobial agents administered both as monotherapy and in combination. The Staphylococcus aureus strain was considerably more difficult to eliminate from catheters than were the Staphylococcus epidermidis strains. This experience gained in the laboratory was then applied in vivo to 16 episodes of catheter sepsis in seven children. Treatment for at least six days with imipenem/cilastatin combined with fosfomycin or an aminoglycoside successfully eliminated the pathogens isolated from 11 of the 16 episodes of infection. The broad-spectrum combination was chosen because it could not be assumed that individual pathogens would be sensitive to a single substance. Nine of the infected catheters could be retained in the patients. This experience suggests that it may be possible to successfully eliminate the colonization of central venous catheters by coagulase-negative staphylococci using the antimicrobial agents employed here.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425711     DOI: 10.1007/bf01961855

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

1.  Complications of Hickman-Broviac catheters.

Authors:  M E Pessa; R J Howard
Journal:  Surg Gynecol Obstet       Date:  1985-09

2.  Problems associated with indwelling central venous catheters.

Authors:  P J Darbyshire; N C Weightman; D C Speller
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

3.  Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response.

Authors:  E D Gray; G Peters; M Verstegen; W E Regelmann
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

4.  Bacterial pathogens in patients with indwelling venous catheters.

Authors:  G W Fischer; P Zawadsky; D Shanks; D Maybee; R Anderson; V F Garcia; T Olson
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

5.  Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters.

Authors:  G Peters; R Locci; G Pulverer
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

Review 6.  Central venous catheter infections.

Authors:  M D Decker; K M Edwards
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

7.  Broviac central venous catheterization in infants and children.

Authors:  T R Weber; K W West; J L Grosfeld
Journal:  Am J Surg       Date:  1983-02       Impact factor: 2.565

  7 in total
  9 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  Diagnosis of intravascular device related sepsis by a continuous monitoring blood culture system.

Authors:  D Bernard; G Verschraegen; G Claeys; J Bellon; M Vaneechoutte
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

3.  Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.

Authors:  Torben Ostendorf; Andrea Meinhold; Christoph Harter; Hans Salwender; Gerlinde Egerer; Heinrich K Geiss; Antony D Ho; Hartmut Goldschmidt
Journal:  Support Care Cancer       Date:  2005-04-16       Impact factor: 3.603

Review 4.  Current guidelines for the treatment and prevention of nosocomial infections.

Authors:  E Bergogne-Bérézin
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

5.  Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.

Authors:  Russell E Lewis; Dimitrios P Kontoyiannis; Rabih O Darouiche; Issam I Raad; Randall A Prince
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Reducing catheter-associated infections with silver-impregnated catheters in long-term therapy of children.

Authors:  R T Carbon; S Lugauer; U Geitner; A Regenfus; M Böswald; J Greil; T Bechert; S I Simon; H P Hümmer; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 7.  A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters.

Authors:  J P Guggenbichler; M Böswald; S Lugauer; T Krall
Journal:  Infection       Date:  1999       Impact factor: 7.455

Review 8.  Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition.

Authors:  Dane Christina Daoud; Geert Wanten; Francisca Joly
Journal:  Nutrients       Date:  2020-02-10       Impact factor: 5.717

Review 9.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.